PHILADELPHIA, Feb. 15, 2013 /PRNewswire/ -- Allazo Health's CEO, Clifford Jones will be presenting at the 19th annual Wharton Health Care Conference today. Other speakers include Bruce Broussard , President and CEO of Humana; Gary L. Gottlieb , MD, President and CEO of Partners HealthCare; and Kent Thiry , Co-Chairman and CEO of DaVita.
During the presentation, Jones will discuss details of Allazo Health's AllazoEngine™ and share data on the impact it has had on improving patients' medication adherence.
Allazo Health's AllazoEngine, is an analytics service that provides an effective and cost-efficient solution to the complex problem of medication non-adherence for health insurers, pharmacy benefit management companies, integrated delivery networks, and accountable care organizations. Allazo Health's unique proprietary technology not only predicts which patients will be non-adherent to each of their medications, but also predicts how individual patients will respond to various types of intervention efforts. Intervention methods, for example calls from a pharmacist when patients start new medications, informational mailings, or automated calls when patients are late to refill their medication, impact medication adherence in different ways for different patients. By analyzing patient data with its patent pending AllazoEngine, Allazo Health provides clients with an optimal medication adherence intervention strategy targeted to individual patients.
AllazoEngine's analytics financially benefits clients by raising adherence program ROI, reducing medical spending, reducing readmissions, increasing HEDIS scores, and improving Medicare Star ratings.
Jones' experience includes building the Pharmacy Advisor medication adherence program that won awards from URAC and the Pharmacy Benefit Management Institute (PBMI), and has been used with more than 14 million patients.
About Allazo Health:
Allazo Health is an analytics firm that provides medication adherence solutions and services to health insurers, PBMs, integrated delivery networks, and ACOs. Combining cutting-edge behavioral science research, medication adherence expertise, and predictive analytics, Allazo Health is able to forecast patients' adherence to each of their medications and identify the most effective intervention strategies for individual patients. More information about Allazo Health can be found at http://www.allazohealth.com.
Clifford Jones , CEO
About Wharton Health Care Business Conference:
Now in its 19th year, the conference is a leading healthcare forum for industry professionals, policy-makers, and academics. The annual two-day event draws approximately 700 attendees from across the nation. To learn more about the conference, visit http://www.whcbc.org.
|SOURCE Allazo Health|
Copyright©2012 PR Newswire.
All rights reserved